Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

1,241 studies match

clinicaltrialsPublishedShowing 351–400 of 1,241 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01682083	Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD).(COMBI-AD)	completed	Phase 3	870	Novartis PharmaceuticalsINDUSTRY	25	Apr 21, 2026	clinicaltrials
NCT05171075	A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE(MAGNOLIA)	terminated	Phase 3	417	Anthos Therapeutics, Inc.INDUSTRY